Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic

Sexually Transmitted Diseases

Volumn 38, Issue 7, 2011, Pages 672-674

  Rivers, Charles A ^a   Adaramola, Oluwaseun O ^b   Schwebke, Jane R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIXED INFECTION; PREVALENCE; SYMPTOM; UNITED STATES; VAGINA CANDIDIASIS; VAGINITIS;

ADOLESCENT; ADULT; ALABAMA; AMBULATORY CARE FACILITIES; CANDIDIASIS, VULVOVAGINAL; COINFECTION; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; SEXUALLY TRANSMITTED DISEASES; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 79959632467     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31820fc3b8     Document Type: Article

References (13)

1. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am J Med 1983; 74:14-22. (Pubitemid 13221599)
2. Sparks JM. Vaginitis. J Reprod Med 1991; 36:745-752.
3. Ferris DG, Dekle C, Litaker MS. Women's use of over-thecounter antifungal medications for gynecologic symptoms. J Fam Pract 1996; 42:595-600.
4. Wiesenfeld H, Macio I. The infrequent use of office-based diagnostic tests for vaginitis. Am J Obstet Gynecol 1999; 181:39-41. (Pubitemid 29343328)
5. CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006; 55 (RR-11):49-56.
6. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
7. Stamm WE, Kaetz SM, Beirne MS, et al, eds. The Practitioners Handbook for the Management of STDs. Seattle, WA: University of Washington, 1988.
8. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Statistics for Public Health. Version 2.3.1. Available at: www. OpenEpi.com. Accessed July, 12, 2010.
9. Raymond ML, Rousset F. An exact test for population differentiation. Evolution 1995; 49:1280-1283. (Pubitemid 3025486)
10. Redondo-Lopez V, Meriwether C, Schmitt C, et al. Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis 1990; 17:51-53. (Pubitemid 20110412)
11. McClelland R, Richardson BA, Hassan WM, et al. A prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis. J Infect Dis 2009; 199:1883-1890.
12. Sobel J, Leamna D. Suppressive maintenance therapy of recurrent bacterial vaginosis utilizing 0.75% metronidazole vaginal gel. In: Abstracts of the Second International Meeting on Bacterial vaginosis. Aspen, CO, 1998.
13. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over 12 months following oral metronidazole and factors associated with recurrence. J Infect Dis 2006; 193:1478-1486. (Pubitemid 43794575)